Literature DB >> 11278397

Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts.

W A Campbell1, N L Thompson.   

Abstract

l-amino acid transporter-1 (LAT1) is a highly conserved gene identified as a light chain of the CD98 amino acid transporter and cellular activation marker. In our previous studies we found increased expression of LAT1 in primary human cancers. We have demonstrated also that LAT1 response to arginine availability is lost in transformed and tumorigenic cells such that expression is constitutively high. System l-amino acid transport activity correlates with changes in LAT1. To assess the functional relevance of increased LAT1 expression and the requirement for 4F2 heavy chain, we overexpressed these CD98 subunits together and separately in nontransformed hepatocytes and fibroblasts. Antigen tags in the expression constructs confirmed that expressed proteins were localized to both cytoplasmic and plasma membrane locations within the cells. Overexpression of LAT1 alone in mouse hepatocytes, but not fibroblasts, was sufficient to increase system l transport, and these cells displayed a growth advantage in conditions of limited arginine. Our results suggest that loss of regulation leading to constitutive expression of LAT1 can contribute to oncogenesis. We hypothesize that the altered LAT1 expression observed in hepatocarcinogenesis gives cells a growth or survival advantage through increased transport activity in a tumor microenvironment of limited amino acid availability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278397     DOI: 10.1074/jbc.M008248200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Activation of system L heterodimeric amino acid exchangers by intracellular substrates.

Authors:  Christian Meier; Zorica Ristic; Stefan Klauser; François Verrey
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

2.  LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Authors:  Kuniaki Nakanishi; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Makio Mukai; Eiji Ikeda; Yuichi Ozeki; Shinsuke Aida; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2005-09-21       Impact factor: 4.064

3.  shRNA-mediated Slc38a1 silencing inhibits migration, but not invasiveness of human pancreatic cancer cells.

Authors:  Jing Xie; Zhen Chen; Luming Liu; Ping Li; Xiaoyan Zhu; Huifeng Gao; Zhiqiang Meng
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

4.  Antagonists of the system L neutral amino acid transporter (LAT) promote endothelial adhesivity of human red blood cells.

Authors:  Laura Beth Mann Dosier; Vikram J Premkumar; Hongmei Zhu; Izzet Akosman; Michael F Wempe; Timothy J McMahon
Journal:  Thromb Haemost       Date:  2017-04-06       Impact factor: 5.249

5.  CD98hc (SLC3A2) mediates integrin signaling.

Authors:  Chloe C Feral; Naoyuki Nishiya; Csilla A Fenczik; Heidi Stuhlmann; Marina Slepak; Mark H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

6.  Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.

Authors:  Kuniaki Nakanishi; Sho Ogata; Hirotaka Matsuo; Yoshikatsu Kanai; Hitoshi Endou; Sadayuki Hiroi; Susumu Tominaga; Shinsuke Aida; Hiroyasu Kasamatsu; Toshiaki Kawai
Journal:  Virchows Arch       Date:  2007-07-11       Impact factor: 4.064

7.  Differences in Mouse Hepatic Thyroid Hormone Transporter Expression with Age and Hyperthyroidism.

Authors:  Kathrin Engels; Helena Rakov; Denise Zwanziger; Lars C Moeller; Georg Homuth; Josef Köhrle; Klaudia Brix; Dagmar Führer
Journal:  Eur Thyroid J       Date:  2015-05-27

8.  LAT-1 expression in pre- and post-implantation embryos and placenta.

Authors:  M K Chrostowski; B G McGonnigal; J P Stabila; J F Padbury
Journal:  Placenta       Date:  2009-02-04       Impact factor: 3.481

9.  Overexpression of SLC38A1 is associated with poorer prognosis in Chinese patients with gastric cancer.

Authors:  Jing Xie; Ping Li; Hui-Feng Gao; Jian-Xin Qian; Ling-Yan Yuan; Jie-Jun Wang
Journal:  BMC Gastroenterol       Date:  2014-04-09       Impact factor: 3.067

10.  Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers.

Authors:  Caroline Papin-Michault; Christelle Bonnetaud; Maxime Dufour; Fabien Almairac; Mickael Coutts; Stéphanie Patouraux; Thierry Virolle; Jacques Darcourt; Fanny Burel-Vandenbos
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.